STRATEGIC COLLABORATION AGREEMENTStrategic Collaboration Agreement • January 8th, 2021 • 4D Pharma PLC • Pharmaceutical preparations • Texas
Contract Type FiledJanuary 8th, 2021 Company Industry JurisdictionThis Strategic Collaboration Agreement ("Agreement"), effective as of the 10th day of November, 2017 ("Effective Date"), is entered into by and between The University of Texas M. D. Anderson Cancer Center, with a place of business located at 1515 Holcombe Blvd., Houston, TX 77030, USA ("MD Anderson"), a member institution of The University of Texas System ("System") and 4D pharma plc with a place of business located at 9 Bond Court Leeds LS1 2JZ, United Kingdom ("Company") (MD Anderson and Company each a "Party" and collectively the "Parties").
STRATEGIC COLLABORATION AGREEMENTStrategic Collaboration Agreement • November 25th, 2020 • 4D Pharma PLC • Texas
Contract Type FiledNovember 25th, 2020 Company JurisdictionThis Strategic Collaboration Agreement ("Agreement"), effective as of the 10th day of November, 2017 ("Effective Date"), is entered into by and between The University of Texas M. D. Anderson Cancer Center, with a place of business located at 1515 Holcombe Blvd., Houston, TX 77030, USA ("MD Anderson"), a member institution of The University of Texas System ("System") and 4D pharma plc with a place of business located at 9 Bond Court Leeds LS1 2JZ, United Kingdom ("Company") (MD Anderson and Company each a "Party" and collectively the "Parties").